Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Isogenica Names CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Isogenica Names CEO

Ullman replaces Matthews

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Chris Ullman has been appointed chief executive officer of Isogenica. Dr. Ullman replaces Dr. Kevin Matthews who is leaving the company to pursue other opportunities.
 
Dr. Ullman has been with the company since 2002 and has served as chief scientific officer since 2009. He has been instrumental in developing Isogenica’s strategy and driving its technologies.
 
“Dr. Ullman has worked closely with Dr. Matthews over the last five years and has been at the heart of delivering a fundamental change in the capability and direction of the business. I am sure that Chris will be successful in further developing Isogenica to provide technologies and technology capabilities that are valued by its pharma and biotech partners and academic collaborators,” said Jan-Olof Lundin, Chairman of Isogenica.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters